Ischemia–Reperfusion Injury

It sounds like a contradiction. A tissue is dying for lack of oxygen, you give it oxygen back, and it dies faster. Yet this is one of the most reproducible findings in experimental pathology, and it shapes how cardiologists, transplant surgeons, stroke neurologists, and intensivists practice every day. To restore blood flow is almost always the right thing to do — without it the tissue is simply lost — but the restoration itself carries a price, and understanding that price is what this concept is about.

The term breaks into two halves. Ischemia is the interruption of blood supply, which starves tissue of oxygen and of the glucose and substrates it needs, while also leaving metabolic waste to accumulate. Reperfusion is the return of that blood supply. Ischemia–reperfusion injury is the damage attributable specifically to the second phase — damage that would not have occurred, or would have been less, if reperfusion had happened differently. Note that this article is educational and is not medical advice.

The setup: what ischemia does to a cell

Cells run on adenosine triphosphate (ATP), present at roughly 5 millimolar in a healthy myocyte. Almost all of it comes from oxidative phosphorylation in the mitochondria, which requires oxygen as the final electron acceptor. Cut the oxygen and the electron transport chain stalls within seconds. The cell switches to anaerobic glycolysis, which yields only 2 ATP per glucose instead of the ~30 from full oxidation, and which dumps lactate and protons into the cytoplasm. Intracellular pH falls from about 7.2 toward 6.0–6.4.

ATP is what powers the membrane pumps that hold the cell's ionic order. The Na⁺/K⁺-ATPase fails first; sodium accumulates inside. To bail out that sodium, the cell runs its Na⁺/Ca²⁺ exchanger in reverse, importing calcium. Meanwhile the sarcoplasmic and endoplasmic reticulum can no longer sequester calcium, and the mitochondria, normally a calcium sink, lose their ability to hold it. Cytosolic calcium, normally around 100 nanomolar, climbs toward micromolar levels. The cell swells as osmotic control is lost. Crucially, none of this has yet killed the cell — for a window of time, these changes are reversible. In the myocardium that window is roughly 20 minutes before frank necrosis begins; in neurons, the most oxygen-greedy cells in the body, irreversible injury starts after only 4 to 8 minutes.

While all this is happening, the cell is also unwittingly assembling a weapon. The enzyme xanthine dehydrogenase is proteolytically converted to xanthine oxidase, and the breakdown of stranded ATP produces a pool of hypoxanthine. Xanthine oxidase will eagerly oxidize hypoxanthine — but only if it has molecular oxygen to work with. During ischemia there is none. The gun is loaded and cocked, waiting.

The trigger: oxygen returns

Reperfusion delivers a sudden flood of oxygen to a cell that is acidotic, calcium-loaded, and primed. Three things go wrong almost at once.

First, the oxidative burst. Xanthine oxidase finally meets its oxygen and generates superoxide (O₂·⁻) and hydrogen peroxide. Damaged mitochondrial complexes I and III, restarting abruptly, leak electrons and produce more reactive oxygen species (ROS). Infiltrating neutrophils, summoned by the injury, fire their NADPH oxidase. Within seconds to minutes ROS production overwhelms the cell's antioxidant defenses — superoxide dismutase, catalase, glutathione peroxidase — and lipid membranes, proteins, and DNA are oxidatively shredded. ROS also react with nitric oxide to form peroxynitrite, a particularly destructive species.

Second, the calcium overload becomes catastrophic. As pH suddenly normalizes with washout of accumulated protons, the cell loses the one thing that had been restraining its calcium machinery. The Na⁺/Ca²⁺ exchanger keeps pumping calcium in; the sarcoplasmic reticulum, now re-energized but dysregulated, releases and reuptakes calcium in oscillating waves. In a cardiac myocyte this can drive hypercontracture — the cell tears itself apart by contracting against its rigid, calcium-flooded neighbors.

Third, and tying the first two together, the mitochondrial permeability transition pore (mPTP) opens. This large channel in the inner mitochondrial membrane is held shut during ischemia by the acidic pH. Reperfusion removes that brake at the exact moment calcium is high and ROS are abundant — the precise trifecta that flings the pore open. An open mPTP collapses the proton gradient, so the mitochondrion can no longer make ATP; it swells and ruptures, spilling cytochrome c and other factors that activate caspases and commit the cell to death. The first few minutes of reperfusion are therefore decisive: keep the pore shut through that window and the cell may survive; let it open and the cell is lost.

Why the injury can exceed the original insult

Here is the counterintuitive core. A cell that is reversibly injured at the end of ischemia is not yet dead. Reperfusion can convert that reversible injury into irreversible death by adding the ROS burst, the calcium surge, and the pore opening. Add to this the inflammatory and vascular components — complement activation, neutrophil adhesion, endothelial swelling, and microvascular plugging that produces the no-reflow phenomenon — and the result is a wave of death that can claim more cells than the ischemia alone would have. In well-controlled animal models of myocardial infarction, interventions applied only at the moment of reperfusion can reduce final infarct size substantially, which is the experimental proof that a large fraction of the damage is reperfusion-specific rather than ischemia-specific.

This is not an argument against reperfusion. A permanently occluded coronary artery kills the entire downstream territory; an open one with reperfusion injury still salvages most of it. The clinical goal is to reperfuse and to blunt the injury that reperfusion brings.

Ischemic injury versus reperfusion injury

It helps to separate what the absence of blood does from what its return does. The two phases share a continuous timeline but have distinct mechanisms and, importantly, distinct treatment windows.

Feature	Ischemic injury (no flow)	Reperfusion injury (flow returns)
Primary problem	Oxygen and substrate starvation	Sudden oxygen excess to primed cell
Energy state	ATP collapses >90%, anaerobic glycolysis	ATP synthesis fails if mPTP opens
Reactive oxygen species	Low (no O₂ to react)	Massive burst within seconds–minutes
Calcium	Rises gradually as pumps fail	Spikes; drives hypercontracture
pH	Acidotic (~6.0–6.4), inhibits mPTP	Normalizes abruptly, unleashes mPTP
Reversible?	Yes, for a window (~20 min myocardium)	Often converts reversible to irreversible
Best intervention	Shorten ischemic time; reperfuse	Condition the tissue; protect the mPTP

Where it shows up in the clinic

• Myocardial infarction. The whole point of primary angioplasty or thrombolysis is to reperfuse ischemic myocardium fast. But reperfusion brings reperfusion arrhythmias (accelerated idioventricular rhythm, ventricular fibrillation), myocardial stunning (viable muscle that contracts poorly for hours to days), and microvascular obstruction. "Time is muscle" — every minute of delay enlarges the infarct.
• Ischemic stroke. Thrombolysis with tPA and mechanical thrombectomy restore cerebral flow, but reperfusion into vessels damaged by ischemia can cause hemorrhagic transformation, the feared bleed into the infarcted brain. The blood–brain barrier, degraded by ROS and matrix metalloproteinases, leaks.
• Organ transplantation. A donor organ is ischemic from the moment of procurement until it is reperfused in the recipient. Cold storage slows but does not stop the priming. Reperfusion injury is a major driver of delayed graft function and of acute kidney injury in transplanted kidneys.
• Acute kidney injury. The renal medulla lives on the edge of hypoxia even in health. Shock followed by resuscitation, or aortic cross-clamping in surgery, produces classic ischemia–reperfusion acute tubular necrosis.
• Limb and mesenteric ischemia. Releasing a tourniquet, repairing an occluded artery, or untwisting a volvulus reperfuses a large ischemic mass. The systemic washout of potassium, lactate, and myoglobin can cause arrhythmia, acidosis, and pigment-induced renal failure — the basis of reperfusion-related compartment syndrome and crush syndrome.
• Cardiac surgery and arrest. The whole-body ischemia of cardiac arrest, followed by the reperfusion of return of spontaneous circulation, produces the post-cardiac-arrest syndrome, a systemic reperfusion injury with multi-organ dysfunction.

Turning the injury down: conditioning and drugs

The most remarkable discovery in this field is that tissue can be made tolerant. Ischemic preconditioning — subjecting tissue to brief, sublethal cycles of occlusion and reperfusion before the main ischemic event — activates protective signaling (the RISK and SAFE kinase pathways, adenosine and bradykinin receptors, ATP-sensitive potassium channels) that keeps the mPTP shut during the later, longer ischemia. In animal hearts this can shrink infarct size by 60–75%. The catch is that you rarely know a heart attack is coming, so preconditioning is mostly useful in planned settings like cardiac surgery.

Postconditioning applies the same logic at the moment of reperfusion: instead of restoring flow in one abrupt rush, brief repeated cycles of reperfusion and re-occlusion ease the tissue back to full flow, blunting the ROS burst and the pH shift. Remote ischemic conditioning — inflating a blood-pressure cuff on an arm or leg in cycles — recruits the same protective pathways through humoral and neural signals, protecting a distant organ such as the heart. Pharmacologic strategies target the same nodes: antioxidants and ROS scavengers, adenosine, and direct mPTP inhibitors such as cyclosporine A, which blocks the pore regulator cyclophilin D. Results in large human trials have been disappointingly inconsistent, a sobering reminder that the messy clinical setting is not the controlled animal lab. The single most reliable lever remains the oldest one: shorten the ischemic time so there is less primed tissue to injure when flow returns.

Necrosis, apoptosis, and the spectrum between

How a cell dies in reperfusion depends on how badly it is hit. Cells with the most severe energy failure and calcium overload die by necrosis — they swell and burst, spilling contents that inflame the neighborhood. Cells that retain enough ATP to run the machinery may instead die by apoptosis, the orderly, programmed route triggered by cytochrome c release through the very mPTP that reperfusion opens. A middle path, necroptosis, and an iron- and lipid-peroxidation-driven path, ferroptosis, are increasingly recognized in reperfused tissue. The mix matters because apoptosis and necroptosis are, in principle, drug-targetable in ways that explosive necrosis is not.